SLC5A2 and heart failure: Regarding prescription practices for heart failure, 10.8% (n=27) of respondents always prescribed SGLT-2 inhibitors, 38.8% (n=97) prescribed them frequently, 32.4% (n=81) occasionally, and 18% (n=45) never prescribed them.